<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04312958</url>
  </required_header>
  <id_info>
    <org_study_id>HEMCS-032</org_study_id>
    <nct_id>NCT04312958</nct_id>
  </id_info>
  <brief_title>Quantra QStat in Trauma and Liver Transplant</brief_title>
  <official_title>Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma and Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HemoSonics LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HemoSonics LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center prospective, observational study of the Quantra System with the QStat&#xD;
      Cartridge in trauma patients and patients undergoing liver transplant.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Quantra System is a fully integrated and automated in vitro diagnostic device which uses&#xD;
      SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic&#xD;
      properties of a whole blood sample during coagulation. The QStat Cartridge was developed to&#xD;
      monitor hemostasis in patients that may experience a range of coagulopathies of various&#xD;
      etiologies, including fibrinolytic defects. These patients include the trauma and liver&#xD;
      transplant populations. The cartridge consists of four independent channels each containing&#xD;
      different sets of reagents, which provide four measurements performed in parallel yielding&#xD;
      five parameters that depict the functional status of a patient's coagulation system.&#xD;
&#xD;
      This multi-center, prospective, observational pilot study will evaluate the performance of&#xD;
      the Quantra System with the QStat Cartridge as compared to conventional viscoelastic testing&#xD;
      methods in blood samples obtained from trauma patients and patients undergoing liver&#xD;
      transplant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 20, 2020</start_date>
  <completion_date type="Anticipated">June 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results</measure>
    <time_frame>Upon arrival of trauma subject to the emergency department</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results</measure>
    <time_frame>Baseline, immediately before the start of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results</measure>
    <time_frame>During anhepatic phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results</measure>
    <time_frame>During post-reperfusion phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results</measure>
    <time_frame>Upon arrival of trauma subject to the emergency department</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results</measure>
    <time_frame>Baseline, immediately before the start of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results</measure>
    <time_frame>During anhepatic phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results</measure>
    <time_frame>During post-reperfusion phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results</measure>
    <time_frame>Upon arrival of trauma subject to the emergency department</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results</measure>
    <time_frame>Baseline, immediately before the start of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results</measure>
    <time_frame>During anhepatic phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results</measure>
    <time_frame>During post-reperfusion phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results</measure>
    <time_frame>Upon arrival of trauma subject to the emergency department</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results</measure>
    <time_frame>Baseline, immediately before the start of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results</measure>
    <time_frame>During anhepatic phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results</measure>
    <time_frame>During post-reperfusion phase of liver transplant surgery</time_frame>
    <description>Coagulation function assessed by Quantra and ROTEM Delta</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Hemorrhage</condition>
  <condition>Trauma</condition>
  <condition>Liver Transplant</condition>
  <arm_group>
    <arm_group_label>Trauma patients</arm_group_label>
    <description>Trauma patients experiencing traumatic injuries requiring a full trauma team response.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liver transplant patients</arm_group_label>
    <description>Patients undergoing liver transplant surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantra System</intervention_name>
    <description>Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.</description>
    <arm_group_label>Liver transplant patients</arm_group_label>
    <arm_group_label>Trauma patients</arm_group_label>
    <other_name>Quantra QStat Cartridge</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Potential study participants will be adult (&gt;18 years) trauma patients or patients&#xD;
        undergoing liver transplant surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is &gt; 18 years&#xD;
&#xD;
          -  Subject is a trauma patient experiencing traumatic injuries requiring a full trauma&#xD;
             team response OR Subject is a patient undergoing liver transplant surgery.&#xD;
&#xD;
          -  Subject, or subject's legally authorized representative (LAR), is willing to provide&#xD;
             informed consent, either prospectively or by deferred consent, OR Institutional Review&#xD;
             Board (IRB)/Ethics Committee (EC) has waived the requirement to obtain informed&#xD;
             consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is younger than 18 years of age&#xD;
&#xD;
          -  Subject is pregnant.&#xD;
&#xD;
          -  Subject is incarcerated at the time of the study.&#xD;
&#xD;
          -  Subject is currently enrolled in a distinct study that might confound the result of&#xD;
             the proposed study&#xD;
&#xD;
          -  Subject is affected by a condition that, in the opinion of the surgical team, may pose&#xD;
             additional risks.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Zuckerberg San Francisco General Hospital and Trauma Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Shands Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Medical Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Sciences Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>March 15, 2020</study_first_submitted>
  <study_first_submitted_qc>March 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Viscoelastic testing</keyword>
  <keyword>Coagulation</keyword>
  <keyword>Trauma</keyword>
  <keyword>Liver Transplant</keyword>
  <keyword>Quantra</keyword>
  <keyword>QStat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

